Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1193 publications
Mechanically robust PVA/SA semi-IPN hydrogels for highly effective temperature-triggered linagliptin delivery.
Journal: Physical chemistry chemical physics : PCCP
Published: December 05, 2025
Noninsulin drugs for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025
Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis.
Journal: Cureus
Published: October 14, 2025
Linagliptin attenuates kidney cancer in rats via AMPK activation and suppression of YAP/TAZ/HIF-1α signaling.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 05, 2025
Drug hypersensitivity: When systemic symptoms and pustules converge
Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Published: October 02, 2025
Bullous pemphigoid induced by linagliptin: a case series of 17 patients in a rare disease referral center.
Journal: Italian journal of dermatology and venereology
Published: September 24, 2025
Correction: Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats.
Journal: Scientific reports
Published: September 15, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.
Journal: Journal of managed care & specialty pharmacy
Published: September 12, 2025
Correction: Khayat et al. Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis. Microorganisms 2022, 10, 2455.
Journal: Microorganisms
Published: September 01, 2025
Correction to "Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial".
Journal: Diabetes, obesity & metabolism
Published: September 01, 2025
Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review.
Journal: Journal of personalized medicine
Published: August 29, 2025
Last Updated: 01/07/2026